AzTrials
AzTrials

PregnancyMONARCHNCT02626351

Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV Care

A study testing Quality Improvement and Baseline data collection (active comparator) in people with Pregnancy and HIV, run by University of KwaZulu at 1 site in South Africa.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the impact of a quality improvement (QI) intervention on maternal and child healthcare services in seven primary healthcare (PHC) clinics, in a rural setting of KwaZulu-Natal, South Africa. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy, HIV
What is being tested?
Quality Improvement and Baseline data collection (active comparator)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,172 participants
Where
1 siteSouth Africa
Study dates
15 Jul 2015to 30 Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Currently postpartum: immediately post delivery OR 3-6 days postpartum OR 6 weeks postpartum; AND
  • Lives in Africa Centre Demographic Surveillance Area (DSA); AND/OR
  • Attended antenatal care (ANC) or postnatal care (PNC) in study intervention clinics

Who cannot join

  • Below 18 years of age;
  • Not postpartum;
  • Does not live within Africa Centre DSA; AND
  • Did not attend ANC or PNC at study intervention clinics

Trial locations and contacts

1 site in 1 country.

South Africa1 site
  • Africa Centre for Population Health

    Mtubatuba, KwaZulu-Natal, 3935

Other trials in South Africa

About this study

Official title: Optimizing the Delivery of Maternal and Child Health Services to Strengthen the Primary Health Care System in Rural South Africa

This study evaluates the impact of a quality improvement (QI) intervention on maternal and child healthcare services in seven primary healthcare (PHC) clinics, in a rural setting of KwaZulu-Natal, South Africa.

Read the detailed description

INTRODUCTION TO QUALITY IMPROVEMENT Quality Improvement (QI), defined as "systematic and continuous actions that lead to measurable improvement in health care services and the health status of targeted patient groups" (IOM 2014) has roots in the consumer industry as far back as the 1920s. Data-driven structured process improvements have their origins in the consumer industry, particularly motor vehicles, and Avedis Donabedian first described a model for healthcare quality improvement in the 1960s which reflects the same process change model utilised in the consumer industry: the key elements being structures, processes and outcomes. Don Berwick and colleagues founded the Institute for Healthcare Improvement (IHI) in the 1990s, now a leading institution on QI worldwide. The QI approach or 'form' is structured and uses specific QI tools, whereas its application or 'function' is varied depending on selected process interventions and local context. Given the move towards rigorously improving quality of health care worldwide, QI methodology is increasingly gaining popularity not only in high-income settings but also in low- and middle-income countries (LMIC) including South Africa through Department of Health (DoH) commitments to improving quality of health care and reducing disparities thereof.

EVIDENCE BASE FOR QI Whereas QI is increasingly used worldwide including resource-rich settings and resource-limited settings, there is a paucity of scientific evidence assessing causal impact of QI on health outcomes, particularly the gold standard randomized controlled trial. Studies in resource-limited settings suggest a beneficial effect of QI on measured healthcare outcomes however none assessed QI rigorously as a single intervention.

GAPS IN THE PMTCT CASCADE AND INFANT NUTRITION Despite worldwide rollout of antiretroviral therapy (ART) and efforts to prevent mother-to-child transmission (PMTCT), there are still large gaps in coverage with approximately 240,000 infants vertically infected with HIV worldwide, 89% of whom were from the WHO Africa region. South Africa has a very high prevalence of HIV, with a national average of 30% amongst antenatal care (ANC) clients. In the Africa Centre Demographic Surveillance Area (DSA) located within the Hlabisa sub-district of uMkhanyakude district, the HIV prevalence amongst females of reproductive age (15-49 years) ranged from 20-45% in 2011.KwaZulu-Natal province had the highest prevalence of HIV amongst ANC clients of 37.4% in 2012. Furthermore, although KwaZulu-Natal (KZN) had the highest rate of ART coverage amongst HIV-infected pregnant women eligible for ART, the uMkhanyakude district in KZN had ART coverage of only 73% during the same period, far behind the national target of 90%.

Studies have shown inadequate virologic suppression amongst HIV-infected pregnant and breastfeeding (PBF) mothers, and inadequate repeat HIV testing of HIV-negative mothers during the PBF period. Surveillance of PBF mothers in Kenya, Malawi and South Africa demonstrated an HIV seroconversion rate of approximately 4%, illustrating the need to repeat HIV testing through pregnancy and breastfeeding in order to minimize risk of MTCT. Moreover the rate of virologic suppression amongst HIV-infected PBF women varied from 27% (in Kenya) to 72% in Malawi in the same study, and underscores the importance of virologic monitoring to reduce MTCT through virologic suppression. A study in Kenya demonstrated a repeat HIV testing rate of approximately 23% in HIV negative mothers. Given the risk of seroconversion during PBF, the World Health Organisation recommends repeat HIV screening during PBF in high prevalence settings. Although SA has achieved a commendable reduction in MTCT to 2.7% in 2011 at 6 weeks of age in line with the UNAIDS call for virtual elimination of MTCT by 2015, these gaps in PMTCT coverage increase the risk of undetected maternal HIV seroconversion and inadequate virologic suppression and therefore PMTCT achievements to date may be reversed without adequate intervention. Furthermore, given the fertility rate of the population, an MTCT rate of 2.7% with an antenatal HIV prevalence of 30% the number of new infant infections per year in South Africa is concerning high. Preliminary data from the Africa Centre suggest that less than 40% HIV-negative pregnant women undergo re-testing for HIV during pregnancy, whilst approximately 10-20% on lifelong ART (initiated prior to or during the current pregnancy) have virologic failure.

An important component on the agenda for reducing maternal morbidity and mortality is preventing unwanted pregnancies through better uptake of family planning methods. However limitations to contraceptive uptake include lack of knowledge and lack of access in resource-limited settings. According to UNFPA estimates, contraceptive prevalence in South Africa is approximately 65% despite free access to most methods.

Although replacement feeding of HIV-exposed infants might mitigate the risk of MTCT, in resource-limited settings with unreliable access to safe drinking water the high risk of childhood illnesses such as diarrhoea and pneumonia is associated with high rates of mortality. As under 5 childhood mortality in these settings can be reduced significantly by exclusive breastfeeding (EBF), the WHO recommends EBF for HIV-infected and HIV-uninfected mothers, whilst the importance of ART and virologic suppression are further emphasised. These recommendations are endorsed by the South African DoH however stigma associated with EBF by HIV-infected mothers often becomes a barrier to uptake of EBF in general. South Africa had the lowest rates of EBF in the world in 2012 at just 8%.

New South African DoH ART guidelines were implemented in January 2015, notably changing PMTCT guidance to Option B+ (lifelong ART for all pregnant women regardless of CD4 count). HIV screening every 3 months during PBF is also recommended due to the risk of seroconversions given the high prevalence of HIV in South Africa. Furthermore, viral load (VL) testing of PBF on ART is recommended, immediately for those already on ART prior to pregnancy and every 6 months thereafter (assuming VL results are <1000 copies/mL); newly diagnosed PBF women should receive a VL test 3 months after initiating ART and 6 monthly thereafter (assuming VL results are <1000 copies/mL).

THE CONTEXT OF ANTENATAL AND POSTNATAL CARE SERVICES The Africa Centre for Population Health is located in the Hlabisa sub-district of uMkhanyakude district in rural KwaZulu-Natal South Africa. The Africa Centre Demographic Surveillance Area (DSA) covers an area of 438 km2 and is home to the Africa Centre Household Demographic Surveillance System (HDSS), covering approximately 90,000 people from 11,000 households annually. The HDSS is a longitudinal cohort from the early 2000s and collects individual and household information on mortality, fertility, migration, health status and socio-economic data. This provides a nuanced understanding of the study population and enables linking of datasets.

There are 7 primary healthcare clinic (PHC) facilities which are nurse-led in the DSA, providing ANC, PNC and other medical services, and one local district hospital (Hlabisa hospital) which offers some tertiary care services including routine and emergency obstetric care. The number of deliveries occurring in Hlabisa sub-district is estimated at about 3000 per annum.

The local hospital also provides medical doctor support to the PHCs when available. As part of the National Strategic Plan to improve quality of healthcare services, the DoH has rolled out District Clinical Specialist Teams (DCST) including a family physician, paediatrician, anaesthetist, midwife and obstetrician. However the success of staff recruitment to the DCST has been varied. Finally, a local scoping study (unpublished data) of healthcare staff demonstrated gaps in training, supervision and retention of staff with consequent impact on healthcare worker motivation and performance.

STUDY HYPOTHESIS AND JUSTIFICATION Given the nature of overstretched health services, gaps in the PMTCT cascade and infant nutrition illustrated above, a QI intervention is considered most appropriate for optimising clinic processes and therefore healthcare outcomes. It is anticipated that through a real time data-driven approach, process outcomes can be continuously monitored, thereby motivating long term sustainability of changes in clinical practice and improving provider and patient satisfaction with services. Furthermore, QI is a strategy the South African DoH is committed to, as part of improving quality of health services and has worked on several projects with the Centre for Rural Health (CRH), University of KwaZulu-Natal.

The investigators believe this is the first study to causally assess the impact of QI on specified health care outcomes, utilizing a randomised controlled trial (stepped-wedge) study design.

Conditions
Pregnancy, HIV
Being tested
Quality Improvement, Baseline data collection (active comparator)
Keywords
postnatal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quality ImprovementOther

    In a stepped wedge fashion all 7 PHC clinics will receive QI one by one (exception: the two smallest clinics will be rolled into one step). Each step is of 2 months' duration. The study will commence with baseline data collection across all clinics, before the first randomised clinic receives the QI intervention. The QI intervention involves the following activities at each clinic: [1] Situational Analysis: assessment of clinic needs and gaps in processes that influence the specified study endpoints; [2] Intensive Intervention Phase (2 months): the clinic QI team (healthcare facility staff) with support of CRH QI mentors maps clinic processes and establishes priorities for process improvements through identification of bottlenecks, root-causes and commence plan-do-study-act (PDSA) cycles; [3] Maintenance Phase (duration varies for each clinic based on stepped wedge study design): clinic processes are further improved through iterative PDSA cycles; [4] Follow up.

  • Baseline data collection (active comparator)Other

    Endpoint data collection only

Study groups in NCT02626351
Study groupRoleWhat they receive
Receiving/ received QI interventionExperimentalA clinic which is presently receiving the Intensive Phase of the QI intervention, or is in the Maintenance Phase
Receives: Other: Quality Improvement
Not yet received QI interventionActive comparatorA clinic which has not yet received the QI intervention
Receives: Other: Baseline data collection (active comparator)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of HIV-infected pregnant women who are on ART and have received an HIV VL test

    Measured: At study mid-point and study end (approximately 20 months)

  2. Proportion of women who are HIV-uninfected at first ANC HIV test with a repeat antenatal HIV test

    Measured: At study mid-point and study end (approximately 20 months)

Secondary outcomes (12)
  1. Proportion of HIV-infected pregnant women who have HIV virologic suppression

    Measured: At study mid-point and study end (approximately 20 months)

  2. Uptake of exclusive breastfeeding

    Measured: At study mid-point and study end (approximately 20 months)

  3. Uptake of contraception

    Measured: At study mid-point and study end (approximately 20 months)

  4. Proportion of HIV-infected women initiated on ART during pregnancy/breastfeeding (PMTCT)

    Measured: At study mid-point and study end (approximately 20 months)

  5. Number of participants with knowledge of early infant feeding

    Measured: At study mid-point and study end (approximately 20 months)

  6. Number of participants with knowledge of available contraception

    Measured: At study mid-point and study end (approximately 20 months)

  7. Number of participants with knowledge of HIV

    Measured: At study mid-point and study end (approximately 20 months)

  8. Subjective experience: patient satisfaction with services

    Measured: At study mid-point and study end (approximately 20 months)

  9. Subjective experience: provider job satisfaction and motivation

    Measured: At study mid-point and study end (approximately 20 months)

  10. Proportion of infant HIV PCR positivity among HIV-exposed infants (HEI)

    Measured: At study mid-point and study end (approximately 20 months)

  11. Proportion of HEI receiving nevirapine prophylaxis

    Measured: At study mid-point and study end (approximately 20 months)

  12. Proportion of participants enrolled at delivery attending 6-week postnatal visit

    As a measure of retention in care at 6 weeks postpartum

    Measured: At study mid-point and study end (approximately 20 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2015 (estimated)
  2. Study start15 Jul 2015
  3. Primary completion26 Jan 2017
  4. Study completion30 Jan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Single group
Model description
Stepped wedge trial: therefore all clusters receive intervention, in randomised sequence.
Masking
Single blind
Who is masked
Care provider
Enrolment
3,172 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02626351
Sponsor's protocol ID
EuropeAid/134286/L/ACT/ZA
Acronym
MONARCH
Status last verified
Dec 2015
First submitted
23 Oct 2015
Last updated
17 Aug 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Bardfield J, Agins B, Palumbo M, Wei AL, Morris J, Marston B; Cotrimoxazole Qi Group. Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach. Int J Qual Health Care. 2014 Dec;26(6):613-22. doi: 10.1093/intqhc/mzu085. Epub 2014 Oct 21.

    PubMed 25335758
  • Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, Robinson P, Goga A. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013 Jan 1;91(1):70-4. doi: 10.2471/BLT.12.106807. Epub 2012 Nov 19.

    PubMed 23397353
  • Doherty T, Chopra M, Nsibande D, Mngoma D. Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa. BMC Public Health. 2009 Nov 5;9:406. doi: 10.1186/1471-2458-9-406.

    PubMed 19891775
  • Kim YM, Banda J, Kanjipite W, Sarkar S, Bazant E, Hiner C, Tholandi M, Reinhardt S, Njobvu PD, Kols A, Benavides B. Improving performance of Zambia Defence Force antiretroviral therapy providers: evaluation of a standards-based approach. Glob Health Sci Pract. 2013 Aug 14;1(2):213-27. doi: 10.9745/GHSP-D-13-00053. eCollection 2013 Aug.

    PubMed 25276534
  • Maman D, Huerga H, Mukui I et al (2015). Most Breastfeeding Women with High Viral Load Are Still Undiagnosed in Sub-Saharan Africa. Conference on Retroviruses and Opportunistic Infections. Abstract number 32. Available at: http://www.croiconference.org/sessions/most-breastfeeding-women-high-viral-load-are-still-undiagnosed-sub-saharan-africa

  • Mwaniki MK, Vaid S, Chome IM, Amolo D, Tawfik Y; Kwale Improvement Coaches. Improving service uptake and quality of care of integrated maternal health services: the Kenya Kwale District improvement collaborative. BMC Health Serv Res. 2014 Sep 21;14:416. doi: 10.1186/1472-6963-14-416.

    PubMed 25240834
  • Massyn N, Day C, Peer N et al eds (2013/14). District Health Barometer Durban: Health Systems Trust; October 2014.

  • Mutiso P, Simba M, Towett R et al (2014). Effective monitoring of HIV prevention: re-testing HIV-negative clients. 20th International AIDS Conference, Melbourne Australia. Abstract number WEPE178. Available at: http://pag.aids2014.org/abstracts.aspx?aid=7817

  • Statistics South Africa (2014). Mid-Year Population Estimates. Available at: http://www.statssa.gov.za/publications/P0302/P03022014.pdf

  • UNFPA South Africa (2014). Sexual and Reproductive Health. Available at: http://countryoffice.unfpa.org/southafrica/2011/11/24/4255/reproductive_health_and_hiv/

  • UNICEF (2012). UNICEF and WHO welcome South Africa's efforts to protect and support breastfeeding. Available at: http://www.unicef.org/southafrica/media_10469.html

  • Webster PD, Sibanyoni M, Malekutu D, Mate KS, Venter WD, Barker PM, Moleko W. Using quality improvement to accelerate highly active antiretroviral treatment coverage in South Africa. BMJ Qual Saf. 2012 Apr;21(4):315-24. doi: 10.1136/bmjqs-2011-000381.

    PubMed 22438327
  • WHO publications (2014). Global Update on the Health Sector Response to HIV. Available at http://www.who.int/hiv/pub/progressreports/update2014/en/

  • WHO publications (2015). Consolidated Guidelines on HIV Testing Services. Available at: http://www.who.int/hiv/pub/guidelines/hiv-testing-services/en/

  • Zaidi J, Grapsa E, Tanser F, Newell ML, Barnighausen T. Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS. 2013 Sep 10;27(14):2301-5. doi: 10.1097/QAD.0b013e328362e832.

    PubMed 23669155

Questions about this trial

What is this clinical trial studying?

A study testing Quality Improvement and Baseline data collection (active comparator) in people with Pregnancy and HIV, run by University of KwaZulu at 1 site in South Africa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of HIV-infected pregnant women who are on ART and have received an HIV VL test (time frame: At study mid-point and study end (approximately 20 months)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02626351, which also lists 18 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in